These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16240294)

  • 1. Quantitative analysis of shape-specific interactions of Rev response element with a positively charged Rev peptide by capillary electrophoresis.
    Han KC; Yu J; Yang EG
    Electrophoresis; 2005 Nov; 26(22):4379-86. PubMed ID: 16240294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region.
    Wang Y; Hamasaki K; Rando RR
    Biochemistry; 1997 Jan; 36(4):768-79. PubMed ID: 9020774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
    Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
    J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide-triggered conformational switch in HIV-1 RRE RNA complexes.
    Gosser Y; Hermann T; Majumdar A; Hu W; Frederick R; Jiang F; Xu W; Patel DJ
    Nat Struct Biol; 2001 Feb; 8(2):146-50. PubMed ID: 11175904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding kinetics and bioassay of RRE mRNA fragments to a peptide containing the recognition domain of HIV-1 Rev.
    West ML; Ramsdale TE
    Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):85-8. PubMed ID: 9575345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
    Luedtke NW; Tor Y
    Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of mismatch-binding ligands as inhibitors for Rev-RRE interaction.
    Nakatani K; Horie S; Goto Y; Kobori A; Hagihara S
    Bioorg Med Chem; 2006 Aug; 14(15):5384-8. PubMed ID: 16603366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Water, shape recognition, salt bridges, and cation-pi interactions differentiate peptide recognition of the HIV rev-responsive element.
    Michael LA; Chenault JA; Miller BR; Knolhoff AM; Nagan MC
    J Mol Biol; 2009 Sep; 392(3):774-86. PubMed ID: 19631217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted cleavage of HIV rev response element RNA by metallopeptide complexes.
    Jin Y; Cowan JA
    J Am Chem Soc; 2006 Jan; 128(2):410-1. PubMed ID: 16402818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural dynamics of HIV-1 Rev and its complexes with RRE and 5S RNA.
    Lam WC; Seifert JM; Amberger F; Graf C; Auer M; Millar DP
    Biochemistry; 1998 Feb; 37(7):1800-9. PubMed ID: 9485305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity in the binding of aminoglycosides to HIV-RRE RNA.
    Cho J; Rando RR
    Biochemistry; 1999 Jun; 38(26):8548-54. PubMed ID: 10387102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
    Urcuqui-Inchima S; Castaño ME; Hernandez-Verdun D; St-Laurent G; Kumar A
    Retrovirology; 2006 Nov; 3():83. PubMed ID: 17125513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif.
    Chaloin L; Smagulova F; Hariton-Gazal E; Briant L; Loyter A; Devaux C
    J Biomed Sci; 2007 Sep; 14(5):565-84. PubMed ID: 17520355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolvability of the mode of peptide binding by an RNA.
    Iwazaki T; Li X; Harada K
    RNA; 2005 Sep; 11(9):1364-73. PubMed ID: 16043495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
    Sugaya M; Nishino N; Katoh A; Harada K
    J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of HIV Rev peptides containing peptide nucleic acid that bind HIV RRE IIB RNA.
    Kumagai I; Takahashi T; Hamasaki K; Ueno A; Mihara H
    Bioorg Med Chem Lett; 2000 Feb; 10(4):377-9. PubMed ID: 10714504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An anti-apoptotic protein, Hax-1, inhibits the HIV-1 rev function by altering its sub-cellular localization.
    Modem S; Reddy TR
    J Cell Physiol; 2008 Jan; 214(1):14-9. PubMed ID: 17929250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method for detection of specific nucleic acids by recombinant protein with fluorescent resonance energy transfer.
    Endoh T; Funabashi H; Mie M; Kobatake E
    Anal Chem; 2005 Jul; 77(14):4308-14. PubMed ID: 16013840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A heparin-binding peptide from human serum amyloid P component characterized by affinity capillary electrophoresis.
    Heegaard NH
    Electrophoresis; 1998 Mar; 19(3):442-7. PubMed ID: 9551799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.